Cancer Stem Cell-Suppressing Activity of Chrysotoxine, a Bibenzyl from Dendrobium pulchellum

Narumol Bhummaphan1, Varisa Pongrakhananon1, Boonchoo Sritularak1

  • 1Inter-Department Program of Biomedical Sciences, Faculty of Graduate School, Department of Pharmacognosy and Pharmaceutical Botany; Faculty of Pharmaceutical Sciences, Department of Pharmacology and Physiology; and Cell-Based Drug and Health Product Development Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Insights

Chrysotoxine, a natural compound, effectively suppresses cancer stem cell phenotypes in lung cancer by inhibiting the Src/Akt/Sox2 signaling pathway, offering a potential new cancer treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer stem cells (CSCs) drive tumor progression, metastasis, and treatment resistance.
  • Targeting CSCs is crucial for developing effective cancer therapies.
  • Novel therapeutic strategies for CSC targeting are urgently needed.

Purpose of the Study:

  • To investigate the CSC-suppressing activity of chrysotoxine, a bibenzyl compound from *Dendrobium pulchellum*.
  • To elucidate the molecular mechanisms underlying chrysotoxine's effects on CSCs.
  • To evaluate chrysotoxine as a potential therapeutic agent for lung cancer.

Main Methods:

  • Cytotoxicity assays (MTT) on H460 and H23 lung cancer cells.
  • Assessment of CSC-like phenotypes in 3D cultures and extreme limiting dilution assays.
  • Western blot and flow cytometry to analyze CSC markers and signaling proteins (Src, Akt, Sox2).

Main Results:

  • Chrysotoxine significantly reduced the viability of CSC-rich populations and suppressed CSC markers.
  • Chrysotoxine downregulated the Src/protein kinase B (Akt) signaling pathway.
  • Chrysotoxine inhibited Sox2 expression, a key mediator of CSC phenotypes, by suppressing active Src/Akt signaling.

Conclusions:

  • Chrysotoxine exhibits potent CSC-suppressing activity in non-small cell lung cancer.
  • Chrysotoxine targets CSCs by downregulating the Src/Akt/Sox2 signaling axis.
  • Chrysotoxine represents a promising novel therapeutic candidate for cancer treatment.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K